{"id":14125,"date":"2023-05-08T10:32:49","date_gmt":"2023-05-08T08:32:49","guid":{"rendered":"https:\/\/udic.es\/?p=14125"},"modified":"2024-02-14T19:54:21","modified_gmt":"2024-02-14T18:54:21","slug":"new-inhaled-levodopa-inbrija-authorised-in-spain","status":"publish","type":"post","link":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/","title":{"rendered":"New inhaled levodopa INBRIJA authorised in Spain"},"content":{"rendered":"<p>The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical Trial Unit evaluated it during 2015 and 2016.<br \/>\nIt is a new therapy for motor blocks that require an immediate response.<br \/>\nIts use at the request of the patient&#8217;s needs is noteworthy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical Trial Unit evaluated it during 2015 and 2016. It is a new therapy for motor blocks that require an immediate response. Its use at the request of the patient&#8217;s needs is noteworthy.<\/p>\n","protected":false},"author":5,"featured_media":9251,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[130],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>New inhaled levodopa INBRIJA authorised in Spain - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New inhaled levodopa INBRIJA authorised in Spain - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-08T08:32:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-14T18:54:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"815\" \/>\n\t<meta property=\"og:image:height\" content=\"246\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Anais\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anais\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\"},\"author\":{\"name\":\"Anais\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8\"},\"headline\":\"New inhaled levodopa INBRIJA authorised in Spain\",\"datePublished\":\"2023-05-08T08:32:49+00:00\",\"dateModified\":\"2024-02-14T18:54:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\"},\"wordCount\":60,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"articleSection\":[\"Parkinson\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\",\"url\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\",\"name\":\"New inhaled levodopa INBRIJA authorised in Spain - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"datePublished\":\"2023-05-08T08:32:49+00:00\",\"dateModified\":\"2024-02-14T18:54:21+00:00\",\"description\":\"The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"width\":815,\"height\":246,\"caption\":\"logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New inhaled levodopa INBRIJA authorised in Spain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8\",\"name\":\"Anais\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g\",\"caption\":\"Anais\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New inhaled levodopa INBRIJA authorised in Spain - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/","og_locale":"en_US","og_type":"article","og_title":"New inhaled levodopa INBRIJA authorised in Spain - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","og_description":"The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical","og_url":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/","og_site_name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2023-05-08T08:32:49+00:00","article_modified_time":"2024-02-14T18:54:21+00:00","og_image":[{"width":815,"height":246,"url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","type":"image\/png"}],"author":"Anais","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Anais","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#article","isPartOf":{"@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/"},"author":{"name":"Anais","@id":"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8"},"headline":"New inhaled levodopa INBRIJA authorised in Spain","datePublished":"2023-05-08T08:32:49+00:00","dateModified":"2024-02-14T18:54:21+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/"},"wordCount":60,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","articleSection":["Parkinson"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/","url":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/","name":"New inhaled levodopa INBRIJA authorised in Spain - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","datePublished":"2023-05-08T08:32:49+00:00","dateModified":"2024-02-14T18:54:21+00:00","description":"The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured by Acorda and distributed by Esteve. Our Clinical","breadcrumb":{"@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","width":815,"height":246,"caption":"logo"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/en\/"},{"@type":"ListItem","position":2,"name":"New inhaled levodopa INBRIJA authorised in Spain"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8","name":"Anais","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g","caption":"Anais"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/14125"}],"collection":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/comments?post=14125"}],"version-history":[{"count":2,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/14125\/revisions"}],"predecessor-version":[{"id":14132,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/14125\/revisions\/14132"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media\/9251"}],"wp:attachment":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media?parent=14125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/categories?post=14125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/tags?post=14125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}